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Summary
Thedifferentiation potential of T lineage cells becomes
restricted soon after entry of multipotent precursors
into the thymus and is accompanied by a downregula-
tion of the transcription factors C/EBPa and PU.1. To
investigate this restriction point, we have expressed
C/EBPa and PU.1 in fully committed pre-T cells and
found that C/EBPa (and C/EBPb) induced the forma-
tion of functional macrophages. In contrast, PU.1 con-
verted them intomyeloiddendritic cellsunder identical
culture conditions. C/EBPa-induced reprogramming is
complex because upregulation of some but not all
myelomonocytic markers required endogenous PU.1.
Notch signaling partially inhibited C/EBPa-induced
macrophage formation and completely blocked PU.1-
induced dendritic cell formation. Likewise, expression
of intracellular Notch or the transcription factor GATA-
3 inhibited C/EBPa-induced lineage conversion. Our
data show that committed T cell progenitors remain
susceptible to the lineage instructive effects of mye-
loid transcription factors and suggest that Notch sig-
naling induces T lineage restriction by downregulating
C/EBPa and PU.1 in multilineage precursors.
Introduction
T cell development in the thymus occurs in discrete de-
velopmental stages. The earliest stages, the CD42CD82
double-negative 1 (DN1) and DN2 subsets (pro-T cells),
exhibit natural killer (NK) as well as macrophage and
dendritic potentials in culture (Balciunaite et al., 2005;
Benz and Bleul, 2005; Lucas et al., 1998; Porritt et al.,
2004; Schmitt et al., 2004; Shen et al., 2003). Full com-
mitment to the T cell lineage occurs at the DN3 stage, af-
ter which differentiation may proceed to CD4+CD8+ dou-
ble- and CD4+ or CD8+ single-positive cells (Rothenberg
and Taghon, 2005). In the hematopoietic system, cell
fate is determined by specific transcription factors that
establish new gene expression programs during differ-
entiation while suppressing old ones (Cantor and Orkin,
2001; Graf, 2002). However, little is known about which
factors are involved in determining the restriction in
plasticity observed between the pro- T and pre-T (DN3
and DN4) cell stages.
*Correspondence: thomas.graf@crg.esEarly T cell progenitors express the transcription fac-
tor GATA-3 (Hendriks et al., 1999) and the Notch effector
HES1 (Sambandam et al., 2005), and the absence of
GATA-3 or Notch1 leads to a complete failure of T line-
age development (Radtke et al., 1999; Ting et al.,
1996). Therefore, these T cell transcription factors might
be antagonized by transcription factors required for
myelomonocytic-dendritic and NK cell fates during
commitment of pro-T cells to alternative fates. One can-
didate is the bZip family transcription factor C/EBPa,
which is known to be strictly required for the develop-
ment of granulocyte and macrophage precursors
(Zhang et al., 1997, 2004). In addition, when overex-
pressed, this factor induces myelomonocytic differenti-
ation in human multipotent progenitors (Iwama et al.,
2002) and in committed B cell precursors, through the
antagonism of the transcription factor Pax5 (Xie et al.,
2004; Hsu et al., 2006). A closely related family member,
C/EBPb, is also expressed in myelomonocytic cells and
can rescue granulocyte formation in C/EBPa-defective
mice (Jones et al., 2002). Another candidate for an an-
tagonistically acting transcription factor is the Ets family
member PU.1. This factor is required for the C/EBPa-in-
duced reprogramming of B cells into macrophages (Xie
et al., 2004) and, together with C/EBPa, regulates a vari-
ety of myelomonocytic genes (Friedman, 2002). PU.1 is
essential for the development of myelomonocytic cells
(Zhang et al., 1997, 2004), dendritic cells, B cells, and
T cells (Anderson et al., 2000; Guerriero et al., 2000;
McKercher et al., 1996; Scott et al., 1994; Spain et al.,
1999). Overexpression of PU.1 in chicken megakaryo-
cytic-erythroid progenitors induces myelomonocytic
differentiation (Nerlov and Graf, 1998), whereas in hu-
man and chicken myeloid progenitors, it induces the for-
mation of dendritic cells (Bakri et al., 2005; Iwama et al.,
2002). The PU.1 relative Spi-B is upregulated in DN3 cells
and induces dendritic cell differentiation when overex-
pressed in pre-T cells. However, it is probably not re-
quired for this function in vivo because Spi-B knockout
mice contain dendritic cells (Lefebvre et al., 2005).
Here we have studied the effects of C/EBP and PU.1
overexpression on the differentiation potential of pre-T
cells. We found that C/EBPa and C/EBPb induce the for-
mation of inflammatory macrophages whereas PU.1 re-
programs them into myeloid dendritic-like cells. Our
data suggest that the developmental plasticity of early
T cell precursors becomes restricted by the inactivation
of C/EBP and PU.1 and that their enforced re-expres-
sion can reverse T cell commitment by antagonizing
Notch1 and GATA-3.
Results
C/EBPa and PU.1 Are Expressed in Pro-T Cells
and Become Downregulated in Pre-T Cells
A possible molecular explanation for why multipotency
of pro-T cells becomes restricted at the DN3 cell stage
is the downregulation of myeloid and dendritic trans-
cription factors, as was suggested for PU.1 (Anderson
et al., 2002). To test whether they are developmentally
Immunity
732Figure 1. Expression of PU.1, C/EBPa, and C/EBPb in T Cell Progenitors
Sorted DN subsets were analyzed by real-time quantitative RT-PCR analysis for PU.1 (A), C/EBPa (B), and C/EBPb (C) mRNA expression. Values
obtained for DN1, DN2, DN3, and control samples were graphed relative to that of DN4 cells. mRNAs derived from fresh bone marrow (BM)
served as controls. The EGFP gate was set with cells derived from wild-type control mice. The experiments were done three times, yielding
similar results.regulated, we analyzed the expression of C/EBPa,
C/EBPb, and of PU.1 in purified DN1, DN2, DN3, and
DN4 cells by real-time RT-PCR. Because DN1 cells are
heterogeneous (Porritt et al., 2004), the lin2c-
kit+CD44+CD252 subset was isolated, thus eliminating
non-T lineage precursors (see Figure S1 in the Supple-
mental Data available online; Balciunaite et al., 2005;
Ceredig and Rolink, 2002). Both PU.1 and C/EBPa were
found to be expressed in DN1 cells at more than 10-
fold higher rates than in DN3 and DN4 cells, with DN2
cells showing intermediate amounts (Figures 1A and
1B). C/EBPb was not expressed above background
levels (Figure 1C).
Reciprocal Changes in Cell-Surface Marker
Expression Induced in Pre-T Cells
by C/EBPa, C/EBPb, and PU.1
The correlation between the downregulation of myeloid
transcription with the restriction of developmental plas-
ticity raised the possibility that this process can be re-
versed if their expression is restored. To test this, we
used an enforced expression approach with tagged ret-
roviruses. In addition, to unambiguously assign T line-
age origin of reprogrammed cells, we employed a mouse
model in which the T cell lineage could be traced by Cre-
lox technology. These so-called lck ancestry mice were
generated by crossing lckCre with R26R-EYFP mice
(Lee et al., 2001; Srinivas et al., 2001). Cre recombinase
mediates excision of a loxP flanked stop cassette at the
ubiquitous ROSA26 locus, leading to irreversible acti-
vation of EYFP (Figure S2A). When DN subsets were
analyzed, <1% of DN2 cells, w65% of DN3 cells,
and >90% of DN4 cells were EYFP+ (Figures S2B and
S2C). In addition, hematopoietic stem cells are unla-
beled (Ye et al., 2003). In the peripheral blood of lck an-
cestry mice, CD3+ T cells were completely EYFP labeled
while B220+ B cells and Mac-1+ (CD11b) myelomono-
cytic cells were unlabeled (Figure S2D). This shows
that EYFP expression in lck ancestry mice exhibits line-
age as well as stage specificity, with T lineage cells
becoming labeled at the developmental stage where T
cell commitment occurs.
For the enforced expression experiments, DN cells
from lck ancestry mice were infected with retroviruses
containing genes encoding C/EBPa, C/EBPb, and PU.1
as well as with control viruses (Figure 2A). Cells were
plated on S17 stroma with myeloid cytokines and cells
analyzed by FACS, gating on EYFP+ cells that expressedthe infection marker (Figure 2B). Although the number of
control virus-infected cells decreased over time, cells
expressing C/EBPa remained constant and those ex-
pressing C/EBPb or PU.1 even increased in number
(Figure 2C). To monitor cell identity during culture, we
used Thy1 (CD90) as a T cell marker, which is expressed
from the DN2 stage onward (Porritt et al., 2004), and Mac-
1 (CD11b) and Gr-1 (Ly-6G) as myelomonocytic markers.
Most of the C/EBPa-infected cells showed a decrease of
Thy1 and an increase of Mac-1 and Gr-1 expression,
while control virus-infected cells remained unchanged
(Figures 2D and 2E). At days 6 and 8, essentially all C/
EBPa-infected cells were Thyl2/loMac-1+Gr-1+, and sim-
ilar results were obtained with C/EBPb-infected cells
(data not shown). Expression of PU.1 also induced the
formation of Thyl2/loMac-1+ cells but with very different
kinetics: Mac-1 upregulation was faster and Thy1 down-
regulation was slower. In addition, the Mac-1+ cells in-
duced by PU.1 did not express Gr-1 (Figure 2E). These
results were confirmed and extended with sorted DN
subsets from lck ancestry mice: w85% of DN3 cells
andw75% of DN4 cells were Thyl2/loMac-1+ 6 days after
infection with C/EBPa virus (Figures S3A–S3C). In addi-
tion, the infected DN3 cells also downregulated the early
T cell marker CD25 (Figure S3B). Importantly, neither un-
infected nor control retrovirus-infected EYFP+ DN3 or
DN4 cells generated Mac-1+ cells, ruling out a contami-
nation with myeloid or multilineage T cell progenitors.
To obtain a more accurate estimate of the reprogram-
ming frequencies, we performed limited dilution assays
(Figures S4A and S4B): DN3 cells were infected with
C/EBPa, C/EBPb, or control viruses, cultured for 24 hr,
resorted, and seeded at different numbers on S17 stro-
mal cells. The EGFP+ cells were scored microscopically
7 days later. As a control for efficient reprogramming,
cells were also seeded in bulk and analyzed by FACS.
Wells containing control virus-infected DN3 cells never
formed EGFP+ colonies even when plated with 100 cells.
Macrophage-forming frequencies, determined by the
method of maximum likelihood (Fazekas de St Groth,
1982), were found to be 1 in 29.8 and 1 in 34.5 for
C/EBPa and C/EBPb cells, respectively. Because con-
trol virus-infected cells yielded a plating efficiency of 1
in 18.5 on OP9-DL1 stroma (Schmitt and Zuniga-
Pflucker, 2002), we estimate that approximately 60%
of the viable C/EBPa- and C/EBPb-infected DN3 cells
were reprogrammed into macrophages. Together, our
data show that the enforced expression of C/EBP and
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alter their phenotype.
C/EBPa and PU.1 Induce Alternative Cell Fates
Because pre-T cells infected with C/EBPa and C/EBPb
viruses but not those with PU.1 expressed Gr-1, we de-
termined the phenotype of the reprogrammed cells in
more detail. Mac-1+ cells induced by C/EBPa and
C/EBPb were Gr-1+CD62L+CD11c2MHCII2F4/802 (Fig-
ures 3A and 3B), a phenotype characteristic of inflam-
matory macrophages (Geissmann et al., 2003). C/EBPb
cells expressed higher amounts of Gr-1 and were
slightly smaller compared to C/EBPa cells. Mac-1+ cells
generated by PU.1 infection differed dramatically in that
they were Gr-12CD62L2CD11c+MHCII+F4/80lo, resem-
bling myeloid dendritic cells (Shortman and Liu, 2002).
Finally, compared to C/EBP-infected cells, which were
substantially larger (Figures 3B, 3D, and 3E) and more
granular than control cells (Figures 3B, 3C, and 3E),
PU.1-infected cells were smaller (Figure 3B) but ex-
hibited a similar increase in granularity (Figure 3C). In ad-
dition, they formed cytoplasmic extensions (Figure 3F).
These findings show that the enforced expression of
C/EBPa in pre-T cells induces the formation of cells re-
sembling inflammatory macrophages whereas PU.1 in-
duces the formation of myeloid dendritic-like cells under
identical culture conditions.
C/EBP-Induced Macrophage-like Cells
Are Functional and Contain TCR Rearrangements
To determine whether the C/EBP-induced Mac-1+ cells
exhibit functional properties of macrophages, C/EBPb-
infected cells were incubated with opsonized sheep
red blood cells (RBCs). Essentially all of the EYFP+
C/EBPb-infected cells formed rosettes and internalized
them (Figures 3G and 3H). In contrast, nonopsonized
RBCs were neither bound nor internalized (Figures 3I
and 3J). This shows that C/EBPb-reprogrammed cells
exhibit properties of mature macrophages.
Because most pre-T cells contain T cell receptor
(TCR) b rearrangements, we asked whether the reprog-
rammed cells exhibit such rearrangements and indeed
observed polyclonal DJ rearrangement bands in the
C/EBPb reprogrammed (EYFP+hCD4+Mac-1+Thy12)
cells of similar sizes as in control double-positive (DP)
T cells (Figure 4A). By using primers to amplify V-DJ re-
arrangements between Vb5.1 or Vb8.2 and Jb2, we like-
wise observed polyclonal VDJ rearrangement bands in
reprogrammed cells corresponding to a subset of those
seen in DP cells (Figure 4A). Neither DJ nor VDJ rear-
rangements were seen in bone marrow macrophages
(Figures 4A and 4B). These results strongly support the
hypothesis that C/EBPb reprograms T cell precursors
corresponding to the DN3 and DN4 stages.
C/EBPa and C/EBPb Reciprocally Regulate
Macrophage and T Cell-Specific Genes
To obtain a more comprehensive picture about the extent
of the gene-expression changes induced by C/EBP in
pre-T cells, EYFP+ cells infected with C/EBPa, C/EBPb,
or control viruses were sorted 2 and 9 days after infection
and analyzed by semiquantitative RT-PCR. The first
myeloid genes transcribed were those encoding lyso-
zyme and the granulocyte colony-stimulating receptorfor the C/EBPa-infected cells and myeloperoxidase
(MPO) for both the C/EBPa- and C/EBPb-infected cells
(Figure 4C). At day 9, expression of all myeloid genes
tested was evident in both C/EBP-infected samples,
whereas MPO expression was no longer seen. Although
PU.1 expression was undetectable by day 2, it was ap-
parent by day 9 in both C/EBP-infected samples to sim-
ilar amounts as in macrophage controls (Figure 4H). Day
2 C/EBPa cells, and to a lesser extent C/EBPb cells, also
showed the downregulation of lck, preTa, Rag-1, and
Rag-2, with expression of all T cell genes tested becom-
ing undetectable by day 9 (Figure 4D). Remarkably, the
T cell transcriptional regulators Notch1 and GATA-3
appeared to be downregulated already at day 2 by
both C/EBP factors (Figure 4E). We also examined the
mRNA expression of the helix-loop-helix transcription
factors E2A and HEB, which form heterodimers in T cell
progenitors. At day 9, HEB was completely downregu-
lated whereas E2A was slightly decreased and its inhib-
itor Id2 was upregulated. Together, our data show that
the enforced expression of C/EBPa and C/EBPb induces
the activation of myeloid genes and extinction of all T cell
genes tested.
C/EBPa Requires Endogenous PU.1 to Upregulate
Mac-1 but Not Gr-1
Previously, we found that the ability of C/EBPa to upre-
gulate myeloid genes in B lineage cells required endog-
enous PU.1 (Xie et al., 2004). This, together with the
fact that PU.1 is downregulated at the pro-T to pre-T
cell transition (Figure 1B; Anderson et al., 2002), raised
the possibility that the reprogramming of T cell lineage
cells is PU.1 independent. To examine this, we first de-
termined whether PU.1 accelerates the C/EBPa-induced
reprogramming of pre-T cells. This was indeed the case:
PU.1 accelerated C/EBPa-induced Mac-1 upregulation
by approximately 2 days (Figures 5A and 5B). In contrast,
PU.1 influenced neither Gr-1 upregulation (data not
shown) nor Thy1 downregulation (Figure 5C). To test
whether PU.1 is required, we conditionally inactivated
PU.1 in T lineage cells by crossing lckCre mice with
mice containing two alleles of Sfpi1 (gene encoding
PU.1) flanked by loxP elements (Figure 5D). Cross-
ing the R26R-EYFP allele into these mice marked cells
with active Cre. With a similar approach in B cells,
>95% of EYFP+ cells exhibited a deletion in Sfpi1 (Ye
et al., 2005). DN cells from Sfpi1wt/wt, Sfpi1wt/loxp, and
Sfpi1loxp/loxp littermates were infected with C/EBPa,
C/EBPa plus PU.1, or control viruses. Athough C/EBPa
induced expression of Mac-1 in almost 100% of EYFP+
cells from Sfpi1wt/wt and Sfpi1wt/loxp control mice, the
proportion of Mac-1+ cells was reduced to 28% in cells
of mice lacking PU.1 (Sfpi1loxp/loxp), a reduction that
could be rescued by coexpression of PU.1 (Figures 5E
and 5F). A possible explanation for the presence of resid-
ual Mac-1+ cells is that they still contained some PU.1
protein because of a recent excision of PU.1, as indi-
cated by the fact that their antigen level was w10-fold
lower than that of Mac-1+ cells from Sfpi1wt/wt litter-
mates. Incontrast, C/EBPa induced the formationofcells
with high level Gr-1 expression even in the Sfpi1loxp/loxp
background (Figure 5G). These cells were larger than
control virus-infected DN cells and also exhibited in-
creased granularity (Figure 5E, data not shown). Finally,
Immunity
734Figure 2. Effects of Enforced Expression of Myeloid Transcription Factors in Pre-T Cells
(A) Diagrams of retroviruses with or without transcription factors (TF).
(B–E) DN cells from lck ancestry mice were infected with C/EBPa, C/EBPb (linked to hCD4), PU.1 (linked to EGFP), or control retroviruses (hCD4
or EGFP) and cultured on S17 stroma plus SCF, IL-7, Flt3L, IL-3, and M-CSF for 2 to 8 days.
(B) FACS profile showing the gating strategy to analyze EYFP+ cells expressing the coinfection marker hCD4 or EGFP.
(C) Plot of relative cell numbers defined as the percentage of EYFP+-infected cells relative to day 2.
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735Figure 3. Cell-Surface Phenotypes, Morphology, and Phagocytic Capacity of Pre-T Cells Reprogrammed by C/EBPa, C/EBPb, and PU.1
(A) Day 7 cultures of pre-T cells from lck ancestry mice infected with C/EBPa, C/EBPb, and PU.1 were stained with antibodies against macro-
phage- (Gr-1, L-selectin [CD62L]), F4/80) and dendritic (MHC Class II [I-A/I-E], CD11c)-related surface markers. Infected EYFP+Mac-1+ cells were
gated (indicated by bars) and analyzed for expression of each antigen (shaded bars). Open bars show staining with isotype control antibodies.
(B and C) Forward scatter (FSC) (B) and side scatter (SSC) (C) properties of EYFP+-infected cells at day 8. Control virus, black line; C/EBPa, red
line; C/EBPb, orange line; PU.1, green line.
(D and E) Micrographs of control (D) and C/EBPb-infected (E) pre-T cells from lck ancestry mice at day 4 and 12, respectively. Cells labeled in
green (EYFP+) are of T cell origin.
(F) Morphology of a EYFP+EGFP+ cell obtained 12 days after infection with PU.1-EGFP (EGFP) and culture on S17 stroma with cytokines.
(G and H) Day 12 C/EBPb-infected cells after incubation with opsonized RBCs, showing rosetting (G); and after treatment with lysis buffer, show-
ing internalized RBC (H).
(I and J) C/EBPb-infected cells after incubation with nonopsonized RBCs (I) and after treatment with lysis buffer, showing neither rosetting nor
internalization (J). The experiments were performed twice, with similar outcomes.Thy1 was downregulated in EYFP+ C/EBPa-infected
cells from all three genotypes (Figures 5E and 5H). That
the extent of downregulation was even greater in the ab-
sence of PU.1 is possibly because C/EBPa is not seques-
tered in PU.1 complexes (Reddy et al., 2002). These data
show that endogenous PU.1 is required for C/EBPa-
induced upregulation of Mac-1, but not for changes in
Gr-1 and Thy1 expression.Reprogramming Is Impaired when Cells Are Cultured
on OP9 Stromal Cells Expressing Delta-like-1
To examine the effects of Notch signaling on reprogram-
ming, DN cells from lck ancestry mice were infected with
C/EBPa, C/EBPb, PU.1, or control viruses and cultured
on OP9-DL1 (Delta-like-1) stromal cells (Schmitt and Zu-
niga-Pflucker, 2002). Approximately 25% of the EYFP+
C/EBPa-infected cells became Mac-1+Thy12 under(D) Thy1 and Mac-1 expression of virus-infected cells gated for EYFP expression. Quadrant gates were set based on antigen expression of
control virus-infected cells. The numbers indicate percentage of cells in each quadrant.
(E) Kinetics of Mac-1, Gr-1, and Thy1 regulation. For Mac-1 and Gr-1, data are plotted as percentage of antigen-positive cells and for Thy1 as the
geometric mean of fluorescence intensity (MFI, log scale). The experiments were repeated three to four times, yielding similar results.
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736Figure 4. TCR Rearrangements and Gene Expression Profiles of C/EBP-Reprogrammed Pre-T Cells
(A) PCR bands corresponding to products of the TCRb genomic locus between segments Db2.1 and Jb2.7. GL, band corresponding to germline
configuration. Lane 1, DNA from reprogrammed C/EBPb infected pre-T cells (EYFP+hCD4+Mac1+, day 8); lane 2, DNA from CD4+CD8+ thymo-
cytes from a wild-type mouse; lane 3, DNA from bone marrow-derived macrophages; lane 4, H2O control; M, DNA marker.
(B) PCR of VDJ rearrangements, with indicated primer combinations. Lane designations, same as in (A).
(C–E) Semiquantitative RT-PCR analysis of EYFP+hCD4+ cells sorted from infections with C/EBPa, C/EBPb, and control virus at days 2 and 9 of
culture. A CD4+CD8+ cell line (T pos con) and cultured bone marrow macrophages (M pos con) were used as positive controls. Shown are
myelomonocytic genes (C); T lineage genes (D); transcriptional regulators (E).these conditions (Figure 6A), compared to >90% of the
cells on S17 (Figure 2D). Similar results were obtained
when the experiments were performed on OP9 stroma
or when C/EBPb instead of C/EBPa was used for infec-
tion (data not shown). Therefore, C/EBP-induced re-
programming of pre-T cells is partly inhibited by Notch
signaling. Notch signaling completely inhibited PU.1-
induced Mac-1 upregulation, and the cells showed the
increase neither in size nor granularity observed on
S17 stroma. However, the Notch-mediated inhibition of
C/EBP- and PU.1-induced reprogramming could largely
be overcome when both factors were coexpressed
(Figure 6A, bottom).
We also determined whether the nonresponders
(Thy1+Mac-12 cells) observed on OP9-DL1 stroma pro-
gressed along the T cell pathway. Whereas many of thecontrol virus-infected cells became CD4+CD8+, sub-
stantially lower percentages of double-positive cells
were seen with C/EBPa, C/EBPb, PU.1, and C/EBPa
plus PU.1-infected cells (Figure 6B). In addition, in a
repeat experiment that used DN3 cells as a starting pop-
ulation, >90% of the PU.1-infected cells were found to
remain blocked at the DN3 stage. In comparison, this
number was 66%–68% for C/EBPa- and control virus-
infected cells (data not shown). Finally, our data also
showed that expression of C/EBPa decreased cellularity
whereas PU.1 dramatically increased the cell numbers
above those seen in control virus-infected cultures (Fig-
ure 6C). In conclusion, Notch signaling partially inhibits
the reprogramming of pre-T cells into macrophages in-
duced by C/EBPa whereas it completely inhibits PU.1-
induced reprogramming. This antagonism is reciprocal
Lineage Specification
737Figure 5. Role of PU.1 in C/EBPa-Induced Reprogramming
(A–C) Effects of PU.1 coexpression on C/EBPa-induced reprogramming (see also legend of Figures 2B–2E).
(A) Gating strategy for single-infected (hCD4+) or double-infected (EGFP+hCD4+) EYFP+ cells.
(B and C) Kinetics of Mac-1 and Thy1 expression. Control virus (black line), C/EBPa (red line), and C/EBPa plus PU.1 (blue line).
(D) Configuration of alleles used to generate conditional knockout of PU.1 in lck-expressing T cells with numbers indicating exons, triangles
indicating loxP sites, and arrows indicating expression. Gt(ROSA)Sor is the gene name for the ROSA26 locus.
(E–H) DN cells from lck-Cre+R26R-EYFP+Sfpi1wt/wt (Sfpi1wt/wt), lck-Cre+R26R-EYFP+Sfpi1wt/loxp (Sfpi1wt/lox), and lck-Cre+R26R-EYFP+Sfpi1loxp/loxp
(Sfpi1lox/lox) mice were infected with C/EBPa, C/EBPaplus PU.1, or control viruses (hCD4 and EGFP), and cultured on S17 stroma plus cytokines for
6 days.
(E) Analysis of EYFP+ cells infected with control or C/EBPa virus. Cells in gated quadrants indicated by black squares were further analyzed for
Gr-1 expression.
(F–H) Mean expression values plus standard deviation (n = 3) of Mac-1-, Gr-1-, and Thy1-positive cells, scored either as percentage of antigen-
positive cells or mean fluorescence intensity (MFI). Control virus, C/EBPa, and C/EBPaplus PU.1-infected cells are represented by black, red, and
blue bars, respectively. The experiments were done twice, yielding similar results.
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738Figure 6. Effects of Notch Signaling on C/EBP- and PU.1-Induced Cell Reprogramming
DN cells from lck ancestry mice were infected with C/EBPa, PU.1, C/EBPa plus PU.1-EGFP, or control viruses, plated on OP9-DL1 stromal cells
with cytokines, and cultured for 6 days.
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of T cell precursors to progress toward the double-
positive stage.
Activated Notch and GATA-3 Counteract
C/EBPa-Induced Macrophage Reprogramming
The OP9-DL1 experiments showed that Notch1 partially
inhibits the reprogramming induced by C/EBPa. To
explore possible transcription factor antagonisms in-
volved in this process, we determined whether coex-
pression of C/EBPa with T cell transcription factors
counteracts Thy1 downregulation and/or Mac-1 upregu-
lation. For this purpose, DN cells were coinfected with
C/EBPa and viruses encoding the essential T cell tran-
scriptional regulators GATA-3, IC-Notch (the activated,
intracellular form of Notch1), and E47 (the product of
the Tcfe2a gene). For comparison, cells were infected
with C/EBPa and either PU.1, GATA-1, or control virus.
GATA-1 is known to antagonize PU.1, involving direct
protein interactions (Nerlov and Graf, 1998; Rekhtman
et al., 1999). Coexpression of PU.1 accelerated the for-
mation of Mac-1+ cells, consistent with its ability to syn-
ergize with C/EBPa for the expression of myeloid genes
(Figure 7A). In contrast, GATA-1 inhibited Mac-1 upregu-
lation but not Thy1 downregulation, reflecting its known
ability to antagonize PU.1 but not C/EBPa. In contrast,
GATA-3 predominantly blocked Thy1 downregulation,
indicating that it is capable of inhibiting C/EBPa. IC-
Notch, in turn, prevented changes in expression of
both antigens in >75% of the cells, echoing the results
obtained with C/EBPa-infected cells cultured on OP9-
DL1 stroma (Figure 6A). In addition, a large proportion
of the IC-Notch nonresponders became double positive,
while most of the nonresponders coinfected with either
GATA-3 remained CD42CD82 (data not shown). Cells
coexpressing E47 showed only a slight delay in reprog-
ramming. In sum, these data show that activated Notch
as well as GATA-3, but not the E2A product E47, effec-
tively counteract pre-T cell reprogramming induced by
C/EBPa.
A Subset of Pro-T Cells Express the Myeloid
Restricted Marker Lysozyme and Exhibit
T Lineage Potential
Our data indicate that enforced expression of myeloid
transcription factors in committed T cell progenitors
re-establishes their myeloid potential, reversing the ob-
served downregulation of PU.1 and C/EBPa during the
transition from pro-T to pre-T cells (Figure 1). To test
whether PU.1 and C/EBPa are functional in DN cells,
we analyzed the expression of their target gene lyso-
zyme (lyzs) by using an EGFP knockin mouse (Faust
et al., 2000). Approximately 50% of the DN1 cells and
17% of the DN2 cells were EGFP+, while DN3 and DN4
cells were essentially negative (Figure 7B). The EGFP ex-
pression in DN1 cells was comparable to that of HSCs
and corresponded to approximately 1% of that of mye-
lomonocytic cells (Miyamoto et al., 2002; Ye et al., 2003).
A similar expression pattern was recently described forthe gene encoding colony-stimulating factor-1 receptor
(Csf1r) in early T cells (Balciunaite et al., 2005). Next, we
determined the T cell differentiation potential of EGFP+
and EGFP2DN1 cells from lysozyme GFP mice by seed-
ing sorted cells onto OP9-DL1 stroma, distributing 90
single cells for each fraction (Figures 7C–7F). 9 to 11
days later, the wells were analyzed for the presence of
T lineage cells by CD25, CD44, CD4, and CD8 expres-
sion. The plating efficiency of cells in both fractions
was around 60% and all colonies consisted of DN2 to
DN4 T lineage cells, showing similar frequencies for
the EGFP+ and EGFP2 subsets (Figure 7G). These ob-
servations show that a subset of DN1 cells expresses
the myeloid-restricted marker lysozyme and that this
expression neither inhibits nor weakens their T cell dif-
ferentiation potential. Similarly, we had found earlier
that lysozyme-positive CMPs are capable of megakar-
yocytic/erythroid differentiation and that lysozyme-
expressing hematopoietic stem cells retain long-term
repopulation potential (Miyamoto et al., 2002; Ye et al.,
2003).
Discussion
Our results showed that myeloid differentiation potential
of pro-T cells can be recapitulated in fully committed
pre-T cells by the enforced expression of C/EBPa,
C/EBPb, and PU.1. These effects are highly specific be-
cause the C/EBP factors induced the formation of in-
flammatory-type macrophages while PU.1 induced cells
resembling myeloid dendritic cells under identical cul-
ture conditions. The use of a mouse model that permits
lineage tracing from the pre-T cell stage onward, as well
as experiments with purified DN3 and DN4 cells, ruled
out the possibility that our findings were due to the out-
growth of inadvertent myeloid progenitors. In support of
this conclusion is the observation that C/EBP induced
multiple pre-T cell clones to transdifferentiate into mac-
rophages, exhibiting a variety of VDJ rearrangements.
The finding that C/EBPa-reprogrammed cells express
slightly different amounts of Mac-1, Gr-1, and CD62L
than C/EBPb-reprogrammed cells raises the possibility
that they represent different types of macrophages.
Our results show that activated Notch completely in-
hibits the capacity of PU.1 to upregulate Mac-1 without
impairing its ability to block T cell differentiation. Ex-
pression of C/EBPa attenuates this effect, as shown
by the fact that a significant proportion of C/EBPa-in-
fected pre-T cells became Mac-1+ when grown on
OP9-DL1 stroma. The C/EBPa-induced Mac-1 upregu-
lation itself is PU.1 dependent, and this suggests that
C/EBPa inhibits the ability of Notch1 to inhibit PU.1.
This could be either because C/EBPa inactivates a com-
ponent of the Notch signaling machinery or because it
forms a complex with PU.1, protecting it from the inhib-
itory effects of activated Notch. In a broader context, our
observations raise the possibility that the repression of
B cell lineage potential in fetal liver progenitors by sus-
tained Notch-Delta signaling, which results in T cell(A) Analysis of EYFP+EGFP+/hCD4+ cells for expression of Thy1 and Mac-1.
(B) Cell numbers relative to percentage of EYFP+-infected cells at day 2.
(C) Percentage of nonresponders (Thy1+Mac-12) that became double-positive (CD4+CD8+) at days 2, 4, and 6. Similar results were obtained in
two repeat experiments.
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(A) DN cells from lck ancestry mice were infected with either C/EBPa (hCD4) plus control virus or PU.1, GATA-1, GATA-3, IC-Notch, and E47 viruses
(all linked to EGFP), cultured on S17 stroma plus cytokines and analyzed for Thy1 and Mac-1 expression at 2, 4, and 6 days. The percentages of cell
in each quadrant are indicated by numbers. The standard deviation of the percentages was <10% for day 4 C/EBPa cells (n = 4).
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is also due to the inhibition of PU.1 by Notch. The ob-
served increase in cellularity induced by PU.1 in DN cells
grown on OP9-DL1 stroma might reflect the ability of up-
regulated PU.1 to induce T cell leukemia (Rosenbauer
et al., 2005).
The C/EBPa-induced reprogramming of pre-T cells
consists of two separate processes: extinction of T
cell markers and activation of myelomonocytic markers.
Our data suggest that Thy1, the T cell marker that we
have studied most extensively, is regulated by Notch1
and GATA-3 because both of these factors counter-
acted C/EBPa-induced Thy1 extinction and upregulated
Thy1 when expressed in B cell precursors (data not
shown). A similar antagonism as proposed here for
C/EBPa and GATA-3 has also been described for adipo-
cyte differentiation (Tong et al., 2005) and involves a di-
rect interaction between the two proteins (Tong et al.,
2005; W. Ci and T.G., unpublished data). The observed
extinction of GATA-3 expression induced by C/EBPa
might be explained by an interruption of the autoregula-
tory loop of GATA-3 (Ouyang et al., 2000). In addition,
we observed a counteraction by GATA-3 of C/EBPa-
induced Mac-1 upregulation. This is probably due to
a GATA-3:PU.1 antagonism, as has been described for
a later stage in T cell development (Chang et al., 2005).
How C/EBPa induces Notch1 downregulation is not
clear but is not likely to be due to an indirect effect of
GATA-3 inhibition, because Notch1 is not known to be
downstream of GATA-3. Alternatively, Notch1 extinction
could be caused either by the inactivation of another
essential T cell regulator, such as E2A (Ikawa et al.,
2006), or by the direct repression of Notch1 regulatory
sequences.
Like T cell marker extinction, activation of myelomo-
nocytic gene expression induced by C/EBPa is also
complex. Thus, while Mac-1 activation was found to re-
quire the upregulation of and cooperation with endoge-
nous PU.1, Gr-1 was fully activated in the absence of
PU.1. It is possible that the Gr-1+ cells, which have
a large, granular phenotype, correspond to the im-
mature blasts observed in mice with a conditionally in-
activated or knocked-down PU.1 (Iwasaki et al., 2005;
Rosenbauer et al., 2004). The observation that C/EBPa
regulates myelomonocytic targets in both PU.1-depen-
dent and -independent ways might reflect its dual role
in the specification of monocytic and granulocytic line-
ages. How PU.1 downregulates Thy1 and induces the
expression of dendritic genes, in addition to a subset
of myeloid genes, is not clear but probably involves in-
teracting factors that remain to be identified.
The finding that C/EBPa and PU.1 selectively upregu-
late myelomonocytic and dendritic genes in pre-T cells
(with some exceptions, such as Mac-1) is consistent with
experiments showing that overexpression of C/EBPainduces the formation of macrophages in CD34+ human
myeloid progenitors. In contrast, a dominant-negative
form of C/EBP or PU.1 overexpression has been shown
to induce the formation of Langerhans dendritic cells
(Iwama et al., 2002). This implies that excess C/EBPa
inhibits the ability of PU.1 to activate dendritic gene ex-
pression while excess PU.1 inhibits C/EBPa-induced
monocytic genes. The observation that dendritic cells
express higher amounts of PU.1 than macrophages
(Bakri et al., 2005) supports this idea. An antagonism
between PU.1 and C/EBPa has also been described
for monocyte versus neutrophil differentiation (Dahl
et al., 2003). It remains to be determined how C/EBPa
inhibits the upregulation of dendritic targets by PU.1
and how it inhibits the activation of T lineage genes
by Notch1.
The reprogramming experiments described invite
speculations about how lineage commitment is initiated
in multipotent pro-T cells. In line with the observed pro-
miscuous expression in hematopoietic stem cells of lin-
eage-restricted genes (Enver and Greaves, 1998; Miya-
moto et al., 2002; Ye et al., 2003), DN1 cells express, in
addition to T cell factors (Hendriks et al., 1999; Samban-
dam et al., 2005), myelomonocytic/dendritic transcrip-
tion factors and lysozyme. We therefore propose
a model where Notch signaling induces the extinction
of myeloid potential and of myeloid marker expression
in pro-T cells by downregulating C/EBPa and PU.1.
This transition is accompanied by the upregulation of
Thy1 (Porritt et al., 2004), probably because GATA-3
and Notch1 are no longer antagonized by C/EBPa and
PU.1. The model predicts that commitment toward
a macrophage fate occurs in niches that are low in local
Notch ligand concentration or where cells are exposed
to opposing signals emanating from myeloid instructive
cytokine receptors, such as GM-CSFR (Iwasaki-Arai
et al., 2003). As a consequence, GATA-3 and Notch1 be-
come downregulated and C/EBPa and PU.1 upregu-
lated. Lastly, the model predicts that the commitment
toward the dendritic lineage also occurs in niches pro-
tected from Notch signaling. However, how this lineage
is fated is less clear because dendritic cells, like macro-
phages, express both C/EBPa and PU.1 (unpublished
data). It is therefore possible that the decision to be-
come a macrophage or a dendritic cell depends on the
order in which functional amounts of C/EBPa and PU.1
are expressed.
In conclusion, our data suggest that lineage decisions
in early T cell progenitors result from alterations in the
stoichiometry between myeloid/dendritic and T cell-re-
stricted transcription factors, with Notch1 providing a di-
rect link between the transcription factor network and
extracellular cues. Strikingly, fully committed T lineage
cells remain susceptible to lineage reversal induced by
C/EBPa and PU.1 until at least the DN4 stage. Whether(B) DN subsets from lysozyme-EGFP knockin mice were analyzed for EGFP expression (graphed as percent positive cells). The EGFP gate was
set with cells derived from wild-type control mice.
(C) Staining of DN thymocytes from lysozyme EGFP mice to reveal the DN1 subset (square).
(D) FACS profile showing distribution of EGFP+ cells within the DN1 gate.
(E and F) Profiles of sorted EGFP-positive (E) and EGFP-negative (F) cells. After two rounds of sorting, >99% of the cells were CD44hiCD252c-kit+.
Cells were deposited singly in 90 wells, each containing OP9-DL1 stroma.
(G) Summary of phenotypes (indicated in the box) detected by FACS analysis of single EGFP-positive and -negative DN1 cells cultured for 9 and
11 days. The proportions of clones at specific stage of T cell development are shown in the pie diagrams. The plating efficiency for each cell
fraction is indicated at the bottom.
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interesting to determine.
Experimental Procedures
Mice
lckCre+/+ mice (Lee et al., 2001) (Taconic Farms) were crossed with
R26R-EYFPki/ki mice (Srinivas et al., 2001) (provided by F. Costantini,
Columbia University) to generate lineage ancestry (lckCre+/2R26R-
EYFPwt/ki) mice. To generate conditional PU.1, knockout lckCre+/+
R26R-EYFPki/ki mice were crossed with Sfpi1loxp/loxp mice (Iwasaki
et al., 2005) (provided by D. Tenen, Harvard University). The resulting
lckCre+/2R26R-EYFPwt/kiSfpi1loxp/wt mice were intercrossed to
generate mice expressing one or two alleles of lckCre and R26R-
EYFP with different PU.1 genotypes: spfi1wt/wt, spfi1wt/loxp, and
spfi1loxp/loxp. Strains were genotyped by PCR as described (Iwasaki
et al., 2005; Srinivas et al., 2001; Ye et al., 2003). The lysozyme-EGFP
mice were described previously (Faust et al., 2000). Mice were bred
and maintained in the Research Animal Facility at Albert Einstein
College of Medicine in accordance with guidelines from the Institute
for Animal Studies.
Cell Preparations and Sorting
Double-negative (DN) T cells were prepared from thymi of 4-week-
old lck ancestry mice by lineage depletion with Streptavidin microbe-
ads and an AutoMACS cell separator (Miltenyi Biotec) or SpinSep
dense particles (Stem Cell Technologies). For sorting of DN subsets,
depletion was followed by fluorochrome-conjugated antibody label-
ing and sorting with a MoFlo cell sorter (Cytomation). In some exper-
iments, cells were deposited in 96-well plates by the CyCLONE auto-
mated deposition module (Cytomation). Antibodies were purchased
from BD Pharmingen unless otherwise noted. The following biotin-
conjugated antibodies (Abs) were used to label lineage (lin)-positive
thymocytes before lineage depletion: CD3 (145-2C11), CD4 (GK1.5),
CD8a (53-6.7), B220 (RA3-6B2), CD19 (1D3), Mac-1/CD11b (M1/70),
Gr-1 (RB6-8C5), Ter119 (TER-119), I-A/I-E (2G9). For cell sorting
and analysis, lineage-depleted preparations were stained with c-kit
(2B8), CD25 (PC61), and CD44 (IM7) Abs. In addition, preparations
were also stained with Streptavidin-Alexa Fluor 680 (Molecular
Probes) or Streptavidin-APC-Cy7 to detect any remaining lin+
cells. Gates were set with fluorescence minus one (FMO) controls.
DN subsets were defined as DN1 (lin2c-kit+CD44+CD252), DN2
(lin2c-kit+CD44+CD25+), DN3 (lin2CD442CD25+), and DN4
(lin2CD442CD252) (Ceredig and Rolink, 2002).
Real-Time RT-PCR
DN subsets were sorted and RNA used for real-time quantitative RT-
PCR analysis of PU.1, C/EBPa, and C/EBPb mRNA expression. In
addition, fresh bone marrow cells were used as a control, after lysis
of erythrocytes. RNA was extracted with RNeasy Kit (Qiagen). For
each PCR reaction, cDNA from the equivalent of 250 cells was
used as a template. SybrGreen PCR Master Mix (Applied Biosys-
tems) was used for amplification and detection, and PCR reactions
were carried out with the DNA Engine Opticon 2 PCR detection sys-
tem (Biorad). All reactions were carried out in triplicate. CT values
were calculated and normalized to values for a reference gene (b-ac-
tin), and the relative expression ratio was calculated by the Pfaffl
method (Pfaffl, 2001). The CT values for DN1, DN2, DN3, and control
cell samples were expressed relative to DN4 cells, which expressed
background levels of all three factors.
Analysis of T Cell Potential of DN1 Subsets
EGFP+ and EGFP2DN1 cells from 7-week-old lysozyme-EGFP mice
were double-sorted and seeded individually onto 90 wells each of
96-well plates containing OP9-DL1 stroma and SCF, Flt3L, and IL-
7. Colonies were analyzed by FACS 9 and 11 days later with CD25
(PE), CD44 (APC), CD4 (PECy7), and CD8 (PerCP-Cy5.5) antibodies.
All colonies contained at least 500 T lineage cells. Colonies were cat-
egorized by the prevalence of a DN cell stage. Cells that were nega-
tive for all antigens tested and exhibited the expected small size of T
lineage cells were classified as DN4. A DN subset was considered
present if it constituted at least 1% of all T lineage cells in that col-
ony. No CD4 and CD8 cells were found, nor lysozymehi myeloid cells.Flow Cytometry
The following PE, PECy7, APC, or biotin-conjugated antibodies were
used: Thy1.2 (53-2.1), Mac-1 (M1/70), Gr-1 (RB6-8C5), CD4 (RM4-5),
CD8a (53-6.7), CD11c (HL3), I-A/I-E (MHC-II, 2G9), and CD62L (MEL-
14). Biotin was detected by staining with Streptavidin-Alexa Fluor
680 or -APCCy7. Monoclonal antibodies from Caltag Laboratories
(clone S3.5) were used to detect hCD4. Analyses were performed
with a LSRII cytometer (Becton Dickinson) fitted with custom filter/
dichroic mirror sets for detection of EGFP and EYFP (Chroma),
with FlowJo software (Tree Star).
Retroviral Vectors
MSCV-IRES-EGFP, MSCV-IRES-hCD4, MSCV-C/EBPa-IRES-hCD4,
MSCV-C/EBPa-IRES-EGFP, MSCV-C/EBPb-IRES-EGFP, and MSCV-
PU.1-IRES-EGFP were described previously (Xie et al., 2004). MSCV-
C/EBPb-IRES-hCD4 was constructed with mouse C/EBPb cDNA
(provided by P. Scherer, Albert Einstein College of Medicine).
MSCV-E47-IRES-EGFP was constructed with human E47 cDNA
(provided by T. Hoang, U. of Montreal) (Herblot et al., 2000). MSCV-
GATA-3-IRES-EGFP was constructed with the human GATA-3
cDNA (provided by J.D. Engel, U. of Michigan) (Yang et al., 1994).
MSCV-GATA-1-IRES-EGFP was constructed with the mouse
GATA-1 cDNA (provided by A. Skoultchi, Albert Einstein College of
Medicine) (Rekhtman et al., 1999). MSCV-ICNotch-IRES-EGFP (en-
coding human Notch1) was provided by W. Pear (U. of Pennsylvania)
(Pui et al., 1999).
Retroviral Infections and Cell Culture
Preparation of retroviruses and cell infections were performed as
described (Xie et al., 2004). After infection, cells were washed and re-
suspended at 1–5 3 105 cells/mL in RPMI/10% FCS and deposited
on stromal cell layers. A cytokine cocktail of SCF, Flt3L, IL-7, IL-3,
and M-CSF (5–10 ng/mL) was added for all experiments. S17 and
OP9-DL1 stromal cells were cultured as described (Henderson
et al., 1990; Schmitt and Zuniga-Pflucker, 2002). For the experiments
performed to demonstrate dendritic morphology, PU.1-infected
pre-T cells were cultured on S17 stroma with the cytokine cocktail
described above plus 10 ng/mL GM-CSF for 7 days, and EYFP+
EGFP+Mac-1+ cells were sorted and cultured for another 5 days.
Limiting Cell Dilution Assays
DN3 cells from C57BL/6 mice were sorted and infected. 24 hr after
infection, infected (EGFP+) Thy1+ cells were sorted and seeded ei-
ther in bulk at 1000 cells/well or in a limiting dilution. To evaluate re-
programming frequency, infected cells were plated on S17 stroma in
96-well plates (1, 3, 10, 30, 100 cells/well; 20–30 wells/dilution). To
evaluate plating efficiency, control virus-infected cells were plated
on OP9-DL1 stroma in 96-well plates (1, 10, 100 cells/well; 20
wells/dilution). Wells containing EGFP+ colonies were scored as
positive at day 7. Statistical analysis of frequency was calculated
by the method of maximum likelihood (Fazekas de St Groth, 1982).
TCRb Rearrangements
TCRbD-J rearrangements were assayed by PCR with nested primers
to amplify the TCRb genomic locus between segments Db2.1 and
Jb2.7 (Iwasaki-Arai et al., 2003). C/EBPb-infected cells were grown
for 8 days on S17 stroma, at a time point when no T lineage cells sur-
vived, and EYFP+hCD4+Mac-1+Thy12 cells were sorted. Sorted cells
were lysed directly and used as a template for PCR. For each reac-
tion, DNA from 1–53 103 cells was used as template in the first reac-
tion with external primers. 1/5 of this product was used as template in
the second reaction with internal primers. TCRb V-DJ rearrange-
ments were assayed by a single round of PCR with primers to amplify
between Vb5.1 and Jb2, and Vb8.2 and Jb2, as described elsewhere
(Gounari et al., 2002; Wolfer et al., 2002). PCR with Thy1 primers was
performed as a loading control.
Semiquantitative RT-PCR
RNA from sorted cells was extracted with Trizol reagent (Invitrogen)
and treated with DNase I (Roche). cDNA was synthesized with
SuperscriptII reverse transcriptase (Invitrogen). For each reaction,
cDNA derived from 100–500 cells was used as template and prod-
ucts were amplified with gene-specific primers. Bone marrow-de-
rived adherent macrophages and the 16610D9 DP cell line (Bain
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malized to b-actin levels in each sample with cycle numbers within
the linear amplification range.
Fc Receptor and Phagocytosis Assays
Adherent cells from day 12 C/EBPb infections cultured on S17 stro-
mal layers were washed with PBS and concentrated opsonized
sheep RBCs, coated with rabbit anti-sheep Abs, or nonopsonized
sheep RBCs were added. Cells were incubated with RBCs for 30
min and then washed repeatedly. RBCs were lysed with hypotonic
saline. EYFP+ cells were visualized with an Eclipse TE200 inverted
microscope (Nikon) equipped with an ORC100 CCD camera (Hama-
matsu). Images were acquired with Metamorph software (Universal
Imaging Corporation) and processed with Adobe Photoshop (Adobe
Systems).
Supplemental Data
Four Supplemental Figures can be found with this article online at
http://www.immunity.com/cgi/content/full/25/5/731/DC1/.
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103, 11993–11998.
